VYOME HOLDINGS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
VYOME HOLDINGS, INC. (HIND) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $7.31 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $7.31M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $8.04M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.76M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $3.92M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $7.31M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $8.04M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $3.76M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $3.92M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$4.99M 10-Q · filed 2026-08-12 | -$4.99M 10-Q · filed 2025-11-14 |
| 2025-03-31 | -$4.69M 10-Q · filed 2026-08-12 | -$4.69M 10-Q · filed 2025-11-14 |
| 2024-12-31 | -$4.39M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | -$4.09M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$3.97M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | -$6.30M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | -$6.17M 10-K · filed 2026-03-18 | |
| 2021-03-31 | $10.10M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $4.67M 10-Q · filed 2021-05-12 | |
| 2020-09-30 | $5.92M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $7.18M 10-Q · filed 2020-11-06 | |
| 2020-03-31 | $11.07M 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $15.85M 10-Q · filed 2021-05-12 | |
| 2019-09-30 | $20.07M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $8.38M 10-Q · filed 2020-11-06 | $8.39M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $6.52M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $13.11M 10-K · filed 2021-03-12 | |
| 2018-06-30 | $16.05M 10-Q · filed 2019-07-24 | |
| 2018-03-31 | $24.42M 10-Q · filed 2019-07-24 | |
| 2017-12-31 | $35.11M 10-K · filed 2020-02-27 | |
| 2016-12-31 | $64.31M 10-K · filed 2019-02-22 | |
| 2015-12-31 | -$55.14M 10-K · filed 2018-03-05 | |
| 2014-12-31 | -$39.86M 10-K · filed 2018-03-05 | |
| 2013-12-31 | -$30.17M 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |